Peptide Single Use Manufacturing Technology Trends

The way peptide drugs are made is changing fast. Single use manufacturing technology has moved from a niche option to a mainstream choice for peptide production, and adoption is accelerating. The global single use bioprocessing market is expected to reach $35 billion by 2027, with peptide manufacturing being one of the fastest-growing segments.

Single use systems replace traditional stainless steel equipment with disposable plastic components. This sounds simple, but the impact is huge. Companies can set up new production lines faster, reduce contamination risks, and avoid expensive cleaning validation. For peptide manufacturers trying to keep pace with surging demand, single use technology is a significant advantage.

What Is Peptide Single Use Manufacturing?

Single use manufacturing means using disposable plastic containers, tubing, filters, and mixing systems for drug production instead of permanent stainless steel equipment. Each batch uses a fresh set of components, which are then discarded after use.

For peptide manufacturing, this covers everything from mixing and dissolving raw materials to filtration, filling, and freeze-drying preparation. New single use systems can now handle high-concentration peptide solutions, which was a technical challenge in early versions of this technology.

Why Peptide Manufacturers Are Switching

The biggest driver of single use adoption is speed. Building a traditional stainless steel peptide production facility can take three to five years. A single use facility can be operational in one to two years. In a market where being first matters, that time difference is enormous.

Cleaning is another major factor. In traditional manufacturing, every piece of equipment must be thoroughly cleaned and validated between batches. This is time-consuming, expensive, and requires complex documentation. Single use systems eliminate cleaning validation entirely, which saves months of work and millions of dollars.

Cleaning validation for a single stainless steel peptide production line can cost over $2 million and take six months to complete, expenses that single use systems eliminate entirely.

Single Use vs. Traditional Manufacturing: A Comparison

Factor	Traditional Stainless Steel	Single Use Systems
Capital investment	Very high ($50M-$500M+)	Moderate ($10M-$100M)
Facility setup time	3-5 years	1-2 years
Cleaning validation	Required, complex	Not required
Contamination risk	Higher (cross-contamination possible)	Very low (new components each batch)
Flexibility	Low (fixed equipment)	High (modular, reconfigurable)
Ongoing consumable cost	Low	Higher
Waste generation	Low	Higher (plastic waste)
Best for	Large scale, long-term production	Clinical through mid-scale, multiple products

This comparison shows that single use systems are not always the right choice. For large-scale commercial production of a single peptide at very high volumes, traditional systems may still be more cost-effective over the long run.

Key Single Use Components in Peptide Manufacturing

Modern single use manufacturing systems for peptides include many different components. Understanding what each one does helps you plan your production setup.

Single Use Bioreactors and Mixers: These are large plastic bags with mixing mechanisms. They are used for dissolving peptide raw materials, preparing buffers, and mixing formulations. Sizes range from a few liters for lab scale to thousands of liters for commercial scale.

Single Use Filters: Filters for sterilization and clarification come as pre-assembled disposable units. They do not need to be cleaned or re-validated between batches. This saves significant time and labor.

Single Use Tubing and Connectors: All the connections between equipment components are made with pre-sterilized plastic tubing. Sterile connectors allow tubes to be joined without contaminating the product.

Single Use Sensors: Modern plastic bags now come with built-in sensors for pH, temperature, and dissolved oxygen. These sensors work once and are discarded with the bag, eliminating sensor calibration and cleaning steps.

Trends Shaping Peptide Single Use Manufacturing in 2026

Several key trends are driving the evolution of single use technology for peptides this year.

Larger Scale Systems: Early single use systems were limited to relatively small batches. New technology now supports commercial-scale peptide production in single use format, opening the door for larger programs to adopt these systems.

Continuous Manufacturing Integration: Single use components are increasingly being designed to work with continuous manufacturing platforms. This combination offers both the flexibility of single use and the efficiency of continuous production.

Improved Extractables and Leachables Data: One concern with plastic systems is that chemicals can leach from the plastic into the drug product. Suppliers are now providing much better data on what chemicals can come from their materials, making regulatory submissions easier.

Sustainability Improvements: The plastic waste from single use systems is a real concern. Companies are working on recyclable and biodegradable single use components. Some facilities are now collecting used components for specialized recycling programs.

According to a 2025 report by BioPlan Associates, over 75% of new peptide and biologic manufacturing facilities built in the last three years incorporated single use technology as their primary production platform. This marks a dramatic shift from just a decade ago when single use was considered experimental for commercial manufacturing.

Start with single use systems for clinical and early commercial batches, then evaluate a hybrid approach (single use upstream, stainless steel downstream) as your volumes grow past the 2,000 liter scale where consumable costs start to erode the savings.

Regulatory Considerations for Single Use Peptide Manufacturing

Regulatory agencies including the FDA have developed guidance for single use systems in drug manufacturing. The key concern is extractables and leachables, which are chemicals that can migrate from plastic components into the drug product.

Manufacturers must test their single use systems to characterize what chemicals might be present. They must show that these chemicals are below safe limits and will not affect the safety or quality of the drug. This is called an extractables and leachables study, and it is required for any commercial single use manufacturing program.

The FDA has also issued guidance on how to qualify single use systems for use in GMP manufacturing. Working closely with your single use system supplier to get the right documentation package is essential for a smooth regulatory review.

Choosing the Right Single Use Vendor

Not all single use systems are created equal. Choosing the right vendor for your peptide manufacturing program is a critical decision. Here are the key factors to evaluate.

Material Quality: The quality of the plastic film and other materials directly affects extractables and leachables risk. Choose vendors who can provide comprehensive extractables data packages.

Regulatory Support: Does the vendor have experience supporting FDA and EMA submissions? Can they provide the documentation you need for your drug approval package?

Scalability: Will the vendor's systems scale from your current clinical stage to future commercial volumes? Switching vendors mid-development is very disruptive.

Technical Support: Single use systems can have technical issues. Does the vendor have strong technical support available when you need it?

Workforce Needs for Single Use Peptide Manufacturing

Single use manufacturing requires a different skill set than traditional manufacturing. Workers need to know how to assemble complex plastic assemblies correctly every time, often in gowned environments with limited visibility.

Companies need process engineers who understand single use technology, quality specialists who know how to write single use procedures and specifications, and operators who are well trained on assembly procedures. Finding people with all of these skills is challenging in the current market.

PeptideStaff can help you find manufacturing professionals with single use technology experience. Explore our workforce solutions to learn more about how we support peptide manufacturing teams. You can also read about related topics like peptide contract manufacturing on our site.

Tips for Implementing Single Use Technology

If you are planning to adopt single use technology for your peptide program, here are some practical tips to get started right.

Start with a thorough needs assessment. Map out your full production process and identify which steps are good candidates for single use conversion. Not every step needs to be single use.

Engage your vendor early. Single use system design often requires customization. The earlier you involve your vendor in your process design, the smoother the implementation will be.

Plan for supply chain management. Single use components must be ordered, stored, and tracked carefully. A component shortage can shut down production just as surely as an equipment failure.

FAQs

What is single use manufacturing in peptide production?

Single use manufacturing uses disposable plastic components instead of permanent stainless steel equipment for peptide production. Each batch uses new components, which are discarded after use. This eliminates cleaning validation and reduces contamination risk.

What are the main benefits of single use peptide manufacturing?

The main benefits are faster facility setup, elimination of cleaning validation, lower contamination risk, and greater flexibility to produce multiple peptide products in the same facility. Capital costs are also generally lower than for traditional stainless steel facilities.

Are single use systems approved by the FDA for GMP peptide manufacturing?

Yes, single use systems are used in FDA-approved GMP manufacturing facilities. The FDA has issued guidance on qualification and validation of single use systems. Manufacturers must conduct extractables and leachables studies to demonstrate product safety.

What size batches can single use systems handle for peptides?

Modern single use systems can handle batch sizes from a few liters for lab and clinical scale up to thousands of liters for commercial scale production. Technology has advanced significantly in recent years to support larger scale operations.

What is the main downside of single use manufacturing?

The main downsides are higher ongoing consumable costs, plastic waste generation, and potential supply chain risk if components are not available. For very large commercial batches, traditional systems may still be more cost-effective over the long term.

How do I find manufacturing staff experienced with single use technology?

PeptideStaff specializes in placing manufacturing professionals with single use technology experience. Contact us through our workforce solutions page to discuss your hiring needs.